Does N ratio affect survival in D1 and D2 lymph node dissection for gastric cancer?

被引:11
|
作者
Sakcak, Ibrahim [1 ]
Yildiz, Baris Dogu [1 ]
Avsar, Fatih Mehmet [1 ]
Akturan, Saadet [3 ]
Kilic, Kemal [2 ]
Cosgun, Erdal [4 ]
Hamamci, Enver O. [1 ]
机构
[1] Numune Teaching & Res Hosp, Dept Gen Surg 6, TR-06100 Ankara, Turkey
[2] Kafkas Univ, Fac Med, Dept Gen Surg, TR-36000 Kars, Turkey
[3] Etlik Teaching & Res Hosp, DeDepartment Gen Surg, TR-06010 Ankara, Turkey
[4] Hacettepe Univ, Fac Med, Dept Stat, TR-06100 Ankara, Turkey
关键词
Gastric cancer; Lymph node dissection; Node ratio; Tumor nodule metastasis; INDEPENDENT PROGNOSTIC-FACTOR; STAGE MIGRATION; RANDOMIZED TRIAL; GASTRECTOMY; RESECTION; NUMBER; LYMPHADENECTOMY; CLASSIFICATION; METASTASIS; MORBIDITY;
D O I
10.3748/wjg.v17.i35.4007
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To identify whether there could have been changes in survival if lymph node ratio (N ratio) had been used. METHODS: We assessed 334 gastric adenocarcinoma cases retrospectively between 2001 and 2009. Two hundred and sixteen patients out of 334 were included in the study. Patients were grouped according to disection1 (D1) or dissection 2 (D2) dissection. We compared the estimated survival and actual survival determined by pathologic nodes (pN) class and N ratio, and SPSS 15.0 software was used for statistical analysis. RESULTS: Ninety-six (44.4%) patients underwent D1 dissection and 120 (55.6%) had D2 dissection. When groups were evaluated, 23 (24.0%) patients in D1 and 21 (17.5%) in D2 had stage migration (P = 0.001). When both D1 and D2 groups were evaluated for number of pathological lymph nodes, despite the fact that there was no difference in N ratio between D1 and D2 groups, a statistically significant difference was found between them with regard to pN1 and pN2 groups (P = 0.047, P = 0.044 respectively). In D1, pN0 had the longest survival while pN3 had the shortest. In D2, pN0 had the longest survival whereas pN3 had the shortest survival. CONCLUSION: N ratio is an accurate staging system for defining prognosis and treatment plan, thus decreasing methodological errors in gastric cancer staging. (c) 2011 Baishideng. All rights reserved.
引用
收藏
页码:4007 / 4012
页数:6
相关论文
共 50 条
  • [31] Prognostic and predictive value of metastatic lymph node ratio in stage III gastric cancer after D2 nodal dissection
    Chen, Yinbo
    Li, Cong
    Du, Yian
    Xu, Qi
    Ying, Jieer
    Luo, Cong
    ONCOTARGET, 2017, 8 (41) : 70841 - 70846
  • [32] Gallstone Disease after Extended (D2) Lymph Node Dissection for Gastric Cancer
    Tomotaka Akatsu
    Masashi Yoshida
    Tetsuro Kubota
    Motohide Shimazu
    Masakazu Ueda
    Yoshihide Otani
    Go Wakabayashi
    Koichi Aiura
    Minoru Tanabe
    Toshiharu Furukawa
    Yoshiro Saikawa
    Shigeyuki Kawachi
    Yukako Akatsu
    Koichiro Kumai Masaki Kitajima
    World Journal of Surgery, 2005, 29 : 182 - 186
  • [33] The prognostic value of lymph node ratio for local advanced gastric cancer patients with adjuvant chemoradiotherapy after D2 gastrectomy
    Hu, Min
    Zhang, Shu
    Yang, Xue
    Shen, Yali
    Li, Zhiping
    Zhao, Yaqin
    Xu, Feng
    Jiang, Dan
    Wang, Xin
    Wang, Yongsheng
    MEDICINE, 2018, 97 (44)
  • [34] Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage
    Kabsoo Shin
    Se Jun Park
    Jinsoo Lee
    Cho Hyun Park
    Kyo Young Song
    Han Hong Lee
    Ho Seok Seo
    Yoon Ju Jung
    Jae Myung Park
    Sung Hak Lee
    Sang Young Roh
    In-Ho Kim
    BMC Cancer, 19
  • [35] Is There Any Role of Additional Retropancreatic Lymph Node Dissection on D2 Gastrectomy for Advanced Gastric Cancer?
    Eom, Bang Wool
    Joo, Jungnam
    Kim, Young-Woo
    Park, Boram
    Park, Ji Yeon
    Yoon, Hong Man
    Lee, Jun Ho
    Ryu, Keun Won
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (08) : 2669 - 2675
  • [36] Central lymph node metastasis is predictive of survival in advanced gastric cancer patients treated with D2 lymphadenectomy
    Lu, Huiwen
    Zhao, Bochao
    Huang, Rui
    Sun, Yimeng
    Zhu, Zirui
    Xu, Huimian
    Huang, Baojun
    BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [37] RESULTS OF D2 GASTRECTOMY FOR GASTRIC CANCER: LYMPH NODE CHAIN DISSECTION OR MULTIPLE NODE RESECTION?
    Zilberstein, Bruno
    Mucerino, Donato Roberto
    Yagi, Osmar Kenji
    Ribeiro-Junior, Ulysses
    Lopasso, Fabio Pinatel
    Bresciani, Claudio
    Jacob, Carlos Eduardo
    Monteiro Marta Coimbra, Brian Guilherme
    Cecconello, Ivan
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2012, 25 (03): : 161 - 164
  • [38] D1 versus D2 Gastrectomy for Gastric Adenocarcinoma
    Lavy, Ron
    Hershkovitz, Yehuda
    Chikman, Bar
    Shapira, Zahar
    Poluksht, Natan
    Yarom, Nirit
    Sandbank, Judith
    Halevy, Ariel
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2015, 17 (12): : 735 - 738
  • [39] Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer
    Wang, Zhen
    Chen, Jun-Qiang
    Cao, Yun-Fei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (09) : 1138 - 1149
  • [40] Does lymph node ratio (metastasis/total lymph node count) affect survival and prognosis in gastric cancer?
    Topcu, Ramazan
    Sahiner, Ibrahim T.
    Kendirci, Murat
    Erkent, Murathan
    Sezikli, Ismail
    Tutan, Mehmet B.
    SAUDI MEDICAL JOURNAL, 2022, 43 (02) : 139 - 145